
1. methods. 2013 may 1;60(3):242-7. doi: 10.1016/j.ymeth.2013.03.025. epub 2013 mar 
30.

expression, purification refolding self-assembling protein nanoparticle 
(sapn) malaria vaccine.

guo q(1), dasgupta d, doll ta, burkhard p, lanar de.

author information: 
(1)malaria vaccine branch, walter reed army institute research, silver spring,
md 20910-7500, usa.

there many ways present antigens immune system. used a
repetitive antigen display technology relies self-assembly 60
protein chains spherical self-assembling protein nanoparticle (sapn) to
develop vaccine plasmodium falciparum malaria. protein sequence
contains selected b- t-cell epitopes circumsporozoite protein p.
falciparum (pfcsp) and, assembled nanoparticle induces strong,
long-lived protective immune responses pfcsp. describe
the conditions needed promoting self-assembly p. falciparum vaccine
nanoparticle, pfcsp-kmy-sapn, note pitfalls may occur determining
conditions sapn vaccines. attention paid selecting processes
that amenable scale cgmp manufacturing.

published elsevier inc.

doi: 10.1016/j.ymeth.2013.03.025 
pmcid: pmc3733095
pmid: 23548672  [indexed medline]

